NHI vs VTR vs SBRA Stock Comparison

National Health Investors, Ventas and Sabra Health Care REIT Prices as of Nov 13, 2026 Peers: Industry group
VTR Ventas, Inc.
$88.91 +5.4% 1M +15.1% 1Y
Market cap
$45.69B
P/E
174.4x
Revenue (TTM)
$6.78B
Div. yield
0.02%
Healthcare REITs Real Estate
4 wins

Head to Head

11 decided of 12

National Health Investors leads on 7 of the 12 questions below (National Health Investors 7, Ventas 4). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionNHIVTRSBRALeader
Larger companyMarket capitalisation $2.98B $45.69B $5.20B VTR
Cheaper on earningsLower P/E, profitable companies only 4.3x 174.4x 72.7x NHI
Cheaper on forward earningsLower price / next fiscal year consensus EPS 11.7x 164.6x 53.8x NHI
Faster revenue growthRevenue growth, trailing twelve months +28.2% +22.1% +23.4% NHI
More profitableNet margin, trailing twelve months 152.8% 3.9% 7.8% NHI
Better return on capitalReturn on invested capital 24.8% 9.6% 4.4% NHI
Less leveragedLower net debt / EBITDA 1.2x 2.9x 2.9x NHI
Higher dividend yieldTrailing dividend yield 0.00% 0.02% -0.06% –
Better 1-year returnPrice return, last 12 months -18.0% +15.1% +9.4% VTR
Better 5-year returnAnnualised price return, 5 years +2.2%/yr +10.3%/yr +6.7%/yr VTR
Less volatileAnnualised volatility, 1 year 25.0% 23.1% 24.8% VTR
Higher overall scoreMean of the five percentile scores vs peers 77/100 47/100 50/100 NHI

Percentile Scorecard

NHIVTRSBRA

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisNHIVTRSBRA
Valuation 76 #37 of 149 19 #121 of 149 40 #90 of 149
Growth 88 #18 of 147 60 #59 of 147 51 #73 of 147
Profitability 92 #13 of 144 57 #62 of 144 56 #64 of 144
Financial Health 96 #7 of 149 80 #30 of 149 85 #24 of 149
Shareholder Returns 34 #92 of 139 17 #116 of 139 17 #115 of 139
Overall 77 47 50
  • NHI ranked among 150 companies in Property REITs
  • VTR ranked among 150 companies in Property REITs
  • SBRA ranked among 150 companies in Property REITs

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodNHIVTRSBRASPY
1 month -3.6%+5.4%+6.6% -2.0%
3 months -13.7%-2.9%+0.6% -2.8%
6 months -15.6%+1.7%-1.1% +2.0%
Year to date -17.5%+14.9%+7.9% +10.6%
1 year -18.0%+15.1%+9.4% +12.2%
3 years +17.2%+99.8%+40.5% +68.1%
3 years, per year +5.4%+26.0%+12.0% +18.9%
5 years +11.5%+63.0%+38.6% +61.4%
5 years, per year +2.2%+10.3%+6.7% +10.1%
10 years -7.5%+51.3%-0.2% +248.5%
10 years, per year -0.8%+4.2%0.0% +13.3%

Risk

MeasureNHIVTRSBRASPY
Volatility, 1Y 25.0%23.1%24.8% 13.6%
Downside volatility, 1Y 27.5%24.5%22.5% 13.9%
Beta vs S&P 500, 1Y -0.28-0.18-0.13 1.00
Return / volatility, 1Y -0.720.650.38 0.90
Max drawdown, 5Y -30.8%-43.4%-38.7% -25.4%
From 52-week high -30.8%-11.5%-8.7% -3.2%
52-week high $91.02$100.52$22.39 $779.14
52-week low $62.98$74.90$17.67 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleNHIVTRSBRA
P/E now vs peer median 4.4xmedian 26.1x 174.4xmedian 26.1x 73.1xmedian 26.1x
P/S now vs peer median 6.7xmedian 4.3x 6.9xmedian 4.3x 5.8xmedian 4.3x
EV/EBITDA now vs peer median 4.8xmedian 14.5x 13.8xmedian 14.5x 15.7xmedian 14.5x
P/FCF now vs peer median -21.9xmedian 21.4x -17.4xmedian 21.4x -16.4xmedian 21.4x
P/B now vs peer median 1.5xmedian 1.2x 3.0xmedian 1.2x 1.9xmedian 1.2x
PEG now vs peer median 0.06median 1.75 0.70median 1.75 1.85median 1.75

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsNHIVTRSBRA
Revenue $455.76M $6.78B $919.09M
Gross profit – -$906.46M –
Operating income – $2.68B –
Net income $697.46M $271.54M $71.46M
Free cash flow -$138.85M -$2.71B -$325.53M
EPS (diluted) $14.20 $0.51 $0.28
Cash & equivalents $46.56M $202.01M $36.24M
Total debt $1.04B $12.44B $1.36B
Shares (diluted) 49.04M 518.94M 259.82M
Enterprise value $2.85B $44.37B $4.75B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricNHIVTRSBRA
P/E 4.4x 174.4x 73.1x
P/FCF -21.9x -17.4x -16.4x
P/Operating cash flow 13.0x 24.6x 13.4x
P/S 6.7x 6.9x 5.8x
P/B 1.5x 3.0x 1.9x
P/Tangible book 1.5x 3.4x 1.9x
EV/EBITDA 4.8x 13.8x 15.7x
EV/EBIT 5.4x 22.1x 36.1x
EV/Revenue 8.9x 8.7x 7.1x
EV/FCF -29.1x -21.9x -20.1x
EV/Operating cash flow 17.2x 31.0x 16.4x
PEG (3Y EPS CAGR) 0.06 0.70 1.85

Growth

14 metrics
MetricNHIVTRSBRA
Revenue growth (1Y) 28.2% 22.1% 23.4%
Revenue CAGR (3Y) 13.6% 15.7% 12.3%
Gross profit growth (1Y) – -69.0% –
Gross profit CAGR (3Y) – -64.7% –
Operating income growth (1Y) – -4.7% –
Operating income CAGR (3Y) – 23.3% –
Net income growth (1Y) 373.6% 9.8% -59.2%
Net income CAGR (3Y) 87.7% 190.9% 41.1%
EPS growth (1Y) 359.8% -1.7% -61.7%
EPS CAGR (3Y) 80.1% 249.1% 39.6%
Operating cash flow growth (1Y) 3.4% 23.5% 17.4%
Operating cash flow CAGR (3Y) 9.6% 20.0% 11.4%
Free cash flow growth (1Y) -322.7% -11.8% -1,239%
Free cash flow CAGR (3Y) -44.6% -92.9% -59.7%

Profitability

14 metrics
MetricNHIVTRSBRA
Gross margin – -13.4% –
EBITDA margin 183.9% 63.1% 45.3%
Operating margin – 39.5% –
Pretax margin 150.6% 3.2% 7.1%
Net margin 152.8% 3.9% 7.8%
FCF margin -30.5% -39.9% -35.4%
Operating cash flow margin 51.4% 28.2% 43.6%
Return on equity 37.9% 1.8% 2.5%
Return on assets 22.4% 0.9% 1.3%
Return on invested capital 24.8% 9.6% 4.4%
Return on capital employed – – –
Asset turnover 0.1x 0.2x 0.2x
Cash conversion (OCF / net income) 0.3x 7.0x 5.6x
Stock comp / revenue 1.5% 0.6% 1.5%

Financial Health

11 metrics
MetricNHIVTRSBRA
Debt / assets 32.1% 40.6% 22.8%
Debt / equity 0.5x 0.8x 0.4x
Net debt / EBITDA 1.2x 2.9x 2.9x
Debt / FCF -7.5x -4.6x -3.8x
Liabilities / assets 35.3% 48.2% 47.7%
Equity / assets 64.7% 51.8% 52.3%
Interest coverage 12.9x 4.2x 1.6x
Current ratio – – –
Quick ratio – – –
Cash ratio – – –
Altman Z-score – – –

Shareholder Returns

7 metrics
MetricNHIVTRSBRA
Dividend yield 5.9% 2.3% 7.3%
Net buyback yield -3.0% -9.1% -3.8%
Shareholder yield 2.9% -6.8% 3.5%
Payout ratio (earnings) – 359.5% 423.7%
Payout ratio (FCF) – -36.0% -93.0%
Dividend growth (1Y) – 18.6% -6.0%
Dividend CAGR (3Y) – 10.6% -3.0%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusNHIVTRSBRA
Forward P/E 11.7xFY2026 164.6xFY2026 53.8xFY2026
EPS, next fiscal year $5.40FY2026 $0.54FY2026 $0.38FY2026
EPS growth, next FY +78.8%FY2026 0.0%FY2026 -40.6%FY2026
EPS growth, the year after -45.4% +70.4% +94.7%
Revenue, next fiscal year $291.24MFY2026 $7.16BFY2026 $882.92MFY2026
Revenue growth, next FY +7.2%FY2026 +22.8%FY2026 +14.0%FY2026
Revenue growth, the year after -1.6% +5.6% +14.4%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersNHIVTRSBRA
Held by institutions 78.7% 100.0% 100.0%
Institutions holding 305 953 464
Change in shares held, QoQ +11.1% +5.1% +0.7%
Institutions buying 157 527 229
Institutions selling 91 286 147
Buyers to sellers 1.73 1.84 1.56

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

NHIVTRSBRA
NHI 1.00 0.66 0.70
VTR 0.66 1.00 0.68
SBRA 0.70 0.68 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, NHI, VTR and SBRA?

Ventas (VTR) is the largest by market capitalisation: National Health Investors (NHI) $2.98B, Ventas (VTR) $45.69B, Sabra Health Care REIT (SBRA) $5.20B.

Which stock is cheaper, NHI, VTR and SBRA?

National Health Investors (NHI) trades on the lowest price-to-earnings ratio (National Health Investors (NHI) 4.3x, Ventas (VTR) 174.4x, Sabra Health Care REIT (SBRA) 72.7x). On next year's consensus earnings, National Health Investors (NHI) is cheapest (National Health Investors (NHI) 11.7x, Ventas (VTR) 164.6x, Sabra Health Care REIT (SBRA) 53.8x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

National Health Investors (NHI) grew revenue fastest over the trailing twelve months: National Health Investors (NHI) +28.2%, Ventas (VTR) +22.1%, Sabra Health Care REIT (SBRA) +23.4%.

Which company is more profitable?

National Health Investors (NHI) has the highest net margin (National Health Investors (NHI) 152.8%, Ventas (VTR) 3.9%, Sabra Health Care REIT (SBRA) 7.8%). On return on invested capital, National Health Investors (NHI) leads (National Health Investors (NHI) 24.8%, Ventas (VTR) 9.6%, Sabra Health Care REIT (SBRA) 4.4%).

Which stock has performed better?

Over the past year Ventas (VTR) returned the most: National Health Investors (NHI) -18.0%, Ventas (VTR) +15.1%, Sabra Health Care REIT (SBRA) +9.4%. Over five years, Ventas (VTR) compounded fastest (National Health Investors (NHI) +2.2%/yr, Ventas (VTR) +10.3%/yr, Sabra Health Care REIT (SBRA) +6.7%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: National Health Investors (NHI) 0.00%, Ventas (VTR) 0.02%, Sabra Health Care REIT (SBRA) -0.06%. National Health Investors (NHI) and Sabra Health Care REIT (SBRA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Ventas (VTR) has been the steadiest (National Health Investors (NHI) 25.0%, Ventas (VTR) 23.1%, Sabra Health Care REIT (SBRA) 24.8%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, NHI, VTR and SBRA?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, National Health Investors (NHI) leads on 7. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.